Fabry Disease Treatment Market: By Treatment (Enzyme Replacement Therapy, Oral Chaperone Therapy, and Others), By Route of Administration (Oral Route and Intravenous Route), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Latin America, and MEA)

Purchase Option

$ 4400
$ 6600
$ 8900

Fabry Disease Treatment Market size was valued at USD 2,491.2 million in 2022 and is expected to grow at a 7.8% CAGR from 2023 to 2029. Fabry disease is also known as alpha galactosidase-A deficiency disease. Fabry disease is a very rare inherited disorder resulting from the building up of a particular type of fat such as globotriaosylceramide within the body cells. It gets initiated in childhood and symptoms can be observed such as cluster formations, red spots on the skin, concurrent episodes of pain in hands and feet, and impairment in hearing. The increasing prevalence of Fabry disease across the globe along with the growing awareness about the disease and its treatment is expected to drive the Fabry disease treatment market growth. according to the National Fabry Disease Foundation, every year “April” is observed as Fabry Disease Awareness Month. In addition, increasing research and development in diagnosis and treatment procedures such as enzyme replacement therapy, chaperone therapy, and small molecule therapy are expected to boost the market growth over the forecast period. furthermore, growing investments by biopharmaceutical companies to develop novel and effective therapy and investments in gene therapy are expected to further propel the Fabry disease treatment market strategies over the forecast period. however, the high cost of treatment, late diagnosis, and limited market access to diagnostic tests and treatment in developing countries are expected to hinder the growth of the Fabry disease treatment market, only a few patients suffering from rare diseases were able to get an appointment with a medical provider.

Fabry Disease Treatment Market Key Developments:

  • In August 2022, Amicus Therapeutics got approval for their product Galafold from the European Commission For long-term treatment of Fabry disease in above 12 years with amenable mutation.

Fabry Disease Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.8%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Fabry Disease Treatment Market Dynamics

The Fabry disease treatment market is expected to grow over the forecasted period due to the increasing adoption of novel therapies such as enzyme replacement therapy and oral chaperone therapy in the treatment of Fabry disease. Oral chaperone therapy is a developing technology helping in stabilizing the faulty enzymes in Fabry disease patients. This therapy enables the defective enzyme to fold correctly leading to reduced cellular damage and improved enzyme activity. In addition, growing investments in research and development of such novel therapies along with the approval of novel therapies by regulatory bodies is expected to drive the growth of Fabry disease market over the forecast period.

Fabry Disease Treatment Market Segmentation

By Treatment
  • Enzyme Replacement Therapy
  • Oral Chaperone Therapy
  • Others
By Route of Administration
  • Oral Route
  • Intravenous Route
By Distribution channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Geography
  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA

Frequently Asked Questions

The fabry disease treatment market size was valued at USD 2,491.2 million in 2022

The fabry disease treatment market key players are: JCR Pharmaceuticals Co., Ltd. Sanofi Takeda Pharmaceutical Company Limited Amicus Therapeutics, Inc JCR Pharmaceuticals Co., Ltd. ISU ABXIS Amicus Therapeutics Chiesi Farmaceutici S.p.A. Genzyme Corporation Shrine Protalix AVROBIO

The fabry disease treatment market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Key Features of the Reports

  • Fabry Disease Treatment Market provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
1. Executive Summary
2. Global Fabry Disease Treatment Market Introduction 
2.1.Global Fabry Disease Treatment Market  - Taxonomy
2.2.Global Fabry Disease Treatment Market  - Definitions
2.2.1. Treatment
2.2.2.Route of Administration
2.2.3.Distribution channel
2.2.4.Geography
2.2.5.Region
3. Global Fabry Disease Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Fabry Disease Treatment Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Fabry Disease Treatment Market  By  Treatment, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Enzyme Replacement Therapy
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Oral Chaperone Therapy
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Others
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6. Global Fabry Disease Treatment Market  By Route of Administration, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Oral Route
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Intravenous Route
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7. Global Fabry Disease Treatment Market  By Distribution channel, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail Pharmacies
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Online Pharmacies
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Global Fabry Disease Treatment Market  By Geography, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. The Asia Pacific
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Latin America
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. MEA
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. Global Fabry Disease Treatment Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Fabry Disease Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1.  Treatment Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Enzyme Replacement Therapy
10.1.2.Oral Chaperone Therapy
10.1.3.Others
10.2.  Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Oral Route
10.2.2.Intravenous Route
10.3.  Distribution channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital Pharmacies
10.3.2.Retail Pharmacies
10.3.3.Online Pharmacies
10.4.  Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.North America
10.4.2.Europe
10.4.3.The Asia Pacific
10.4.4.Latin America
10.4.5.MEA
10.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Fabry Disease Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1.  Treatment Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Enzyme Replacement Therapy
11.1.2.Oral Chaperone Therapy
11.1.3.Others
11.2.  Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Oral Route
11.2.2.Intravenous Route
11.3.  Distribution channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital Pharmacies
11.3.2.Retail Pharmacies
11.3.3.Online Pharmacies
11.4.  Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.North America
11.4.2.Europe
11.4.3.The Asia Pacific
11.4.4.Latin America
11.4.5.MEA
11.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Fabry Disease Treatment Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1.  Treatment Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Enzyme Replacement Therapy
12.1.2.Oral Chaperone Therapy
12.1.3.Others
12.2.  Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Oral Route
12.2.2.Intravenous Route
12.3.  Distribution channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital Pharmacies
12.3.2.Retail Pharmacies
12.3.3.Online Pharmacies
12.4.  Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.North America
12.4.2.Europe
12.4.3.The Asia Pacific
12.4.4.Latin America
12.4.5.MEA
12.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Fabry Disease Treatment Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1.  Treatment Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Enzyme Replacement Therapy
13.1.2.Oral Chaperone Therapy
13.1.3.Others
13.2.  Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Oral Route
13.2.2.Intravenous Route
13.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital Pharmacies
13.3.2.Retail Pharmacies
13.3.3.Online Pharmacies
13.4.  Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.North America
13.4.2.Europe
13.4.3.The Asia Pacific
13.4.4.Latin America
13.4.5.MEA
13.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Fabry Disease Treatment Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
14.1.  Treatment Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Enzyme Replacement Therapy
14.1.2.Oral Chaperone Therapy
14.1.3.Others
14.2.  Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Oral Route
14.2.2.Intravenous Route
14.3.  Distribution channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Hospital Pharmacies
14.3.2.Retail Pharmacies
14.3.3.Online Pharmacies
14.4.  Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.North America
14.4.2.Europe
14.4.3.The Asia Pacific
14.4.4.Latin America
14.4.5.MEA
14.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.JCR Pharmaceuticals Co., Ltd.
15.2.2.Sanofi
15.2.3.Takeda Pharmaceutical Company Limited
15.2.4.Amicus Therapeutics, Inc
15.2.5.JCR Pharmaceuticals Co., Ltd.
15.2.6.ISU ABXIS
15.2.7.Amicus Therapeutics
15.2.8.Chiesi Farmaceutici S.p.A.
15.2.9.Genzyme Corporation
15.2.10.Shrine
15.2.11.Protalix
15.2.12.AVROBIO
16. Research Methodology 
17. Appendix and Abbreviations 
  • JCR Pharmaceuticals Co., Ltd.
  • Sanofi
  • Takeda Pharmaceutical Company Limited
  • Amicus Therapeutics, Inc
  • JCR Pharmaceuticals Co., Ltd.
  • ISU ABXIS
  • Amicus Therapeutics
  • Chiesi Farmaceutici S.p.A.
  • Genzyme Corporation
  • Shrine
  • Protalix
  • AVROBIO

Adjacent Markets